Clinical Trial Update: A Study Assessing the Safety and Effectiveness of IC2000 and SPY Fluorescence Imaging Systems (SPY-PHI) in the Visualization of Lymphatic Vessels and Identification of Lymph Nodes During Sentinel Lymph Node Biopsy in Subjects With Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating IC2000 and SPY Fluorescence Imaging Systems for visualization of lymphatic vessels and identification of lymph nodes during se…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• IC2000
• SPY Fluorescence Imaging System (SPY-PHI) (SPY Fluorescence Imaging System)

Snippet

Sponsor: Novadaq Technologies ULC, now a part of Stryker | Conditions: Breast Cancer, Lymph Node Mapping | Phase 3 | Status: COMPLETED | Results posted: 2023-09-21